JORDAN SWAYZE: Open Payments
NPI 1184356248 · GURDON, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$432 in 17 payments from 7 companies in 2025. Trend: 2023 $399 · 2024 $436 · 2025 $432
Food & beverage: $432
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $221 |
| Supernus Pharmaceuticals, Inc. | 3 | $60 |
| Novo Nordisk Inc | 3 | $48 |
| ABIOMED | 1 | $39 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $30 |
| Lilly USA, LLC | 1 | $21 |
| PFIZER INC. | 1 | $14 |
Products named: AIRSUPRA, Qelbree, Rybelsus, TRINTELLIX, ZEPBOUND, FARXIGA, NURTEC ODT, Wegovy.
Industry payments across AR — which companies pay providers there.
